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Functionalisation
X-ray photoelectron spectroscopy (XPS)Surfacemodiﬁcation of an implantwith a biomolecule is used to improve its biocompatibility and to reduce post-
implant complications. In this study, a novel approach has been used to functionalise phosphonic acid mono-
layers with a drug. Ti6Al4V components fabricated using selective laser melting (SLM) were functionalised
with Paracetamol (a pharmaceutically relevant biomolecule) using phosphonic acid based self-assembledmono-
layers (SAMs). The attachment, stability of themonolayers on the SLM fabricated surface and functionalisation of
SAMs with Paracetamol were studied using X-ray photoelectron spectroscopy (XPS) and surface wettability
measurements. The obtained results conﬁrmed that SAMs were stable on the Ti6Al4V surface for over four
weeks and then began to desorb from the surface. The reaction used to functionalise the phosphonic acidmono-
layers with Paracetamol was noted to be successful. Thus, the proposed method has the potential to immobilise
drugs/proteins to SAM coated surfaces and improve their biocompatibility and reduce post-implant
complications.
© 2015The Authors. PublishedbyElsevier B.V. All rights reserved. This is anopenaccess article under theCCBY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Selective laser melting (SLM) is a metal-based additive manufactur-
ing (AM) technique, which is gaining considerable interest for biomed-
ical applications due to its ability to fabricate parts with customised and
complex geometries directly from 3Dmodel data [1–5]. However, limi-
tations are present including the materials currently available and the
surface quality of fabricated parts. Some of the biomaterials that can
be processed by SLM include titanium and its alloys (such as Ti6Al4V
and Ti6Al7Nb), cobalt–chromium alloy and 316L stainless steel. Control
over the surface chemistry of an implant is essential since it governs the
surface chemical reactions. It is not always possible to achieve the de-
sired surface chemistry directly from the manufactured part and
hence surfacemodiﬁcations are performed to obtain the desired surface
chemistry.
In recent years, surface modiﬁcation has been performed not just to
improve the surface ﬁnish of the implant but also to make the implants
biocompatible and a drug carrier [6–12]. For example, to reduce the re-
stenosis rate in drug eluting stents (DES), the stents are coated with
polymers containing drugs such as Paclitaxel. In addition, to improved 3D Printing Research Group,
ingham, Nottingham, NG7 2RD,
.D. Goodridge).
All rights reserved. This is an open accebiocompatibility, the implants are coated with biocompatible proteins,
ceramics and other biomaterials. Hence by changing the physicochem-
ical characteristics, material and biological responses are altered [13].
Most implants are coated or surface modiﬁed with biocompatible
materials using techniques such as dip-, spray- or spin-coating or solvent
casting [14,15]. Implants coated with these conventional coating tech-
niques have drawbacks including surface heterogeneity in the type and
distribution of functional groups, hydrophilic or hydrophobic domains
and surface roughness [16]. Limitations of using polymeric carriers for
biomedical applications includeﬁssures, cracks andwaviness of the coat-
ing (leading to uneven drug distribution), inﬂammatory and hypersensi-
tivity reactions [17]. Thus a coating technique that offers unprecedented
control over the location and orientation of chemical groups/biomole-
cules on the surface is essential to cater for current needs.
Self-assembled monolayers (SAMs) are amphiphilic molecules with
head and tail groups. Typically the head group is attached to the surface
that needsmodiﬁcation and the tail group is used to introduce function-
ality [18]. SAMs are formed on a substrate by the adsorption of mole-
cules from a solution and are usually nanosized adding only a few
nanometres of thickness (depending on the alkyl chain) to the implant
surface [19]. SAMs can be designed at the molecular level to be biologi-
cally inert and can be expanded uniformly (to cover the whole implant
surface)with the implant surfacemaintaining their assembly, structural
integrity and chemical composition. SAMs are inexpensive and versatiless article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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sistance, nano-fabrications, molecular recognition for sensors, drug de-
livery and biocompatibility [20,21].
Various biomolecules including proteins, peptides, carbohydrates,
antibodies and therapeutics have been attached to SAMs for biomedical
applications [22]. Since SAMs can serve as a localised drug delivery sys-
tem, the use of SAMs to attach drugs to biomedical implants is gaining
considerable interest. There are several literature examples of the func-
tionalisation of monolayers with drugs [11,17,23,24]. However, these
drugs are either physisorbed or both physisorbed and covalently bound.
A method was proposed by Mani et al. [17] to successfully bind Pac-
litaxel to SAM coated surfaces; however, it has a number of limitations.
In their procedure, amicrodropmethodwas used to drop the drug solu-
tion on to the cobalt–chromium surface. It was reported that from the
25 μg of drug placed on the surface (1 cm2), only 25% of the drug was
adsorbed to the surface and the rest was washed away by solvent
cleaning. Although a certain amount of the drug can be recovered by
recycling, this method can be time consuming and expensive. Also it
should be noted that scaling up of this method will be difﬁcult since
coating drugs on implants with complex geometries using microdrop
deposition would be challenging. Furthermore, the drug adsorbed on
the surface was observed to be crystallised. Crystallisation of drugs on
an implant surface can potentially increase the surface roughness of
the implant and may cause post-implant complications. Also due to
crystallisation, controlling drug release from the implant surface will
be problematic.
In this study, one-to-one binding of a drug directly to monolayers
adsorbed on a SLM surface was studied. The surface of a SLM-
manufactured part was used due to the increased interest in the use of
SLM to fabricate biomedical implants [3,25–27]. By allowing the mono-
layers to react with drugs under optimal reaction conditions, drugs can
be covalently bound to the monolayers. Such binding can avoid
crystallisation of drugs on the implant surface and reduce the loss of
drugs whilst coating. In this study, the stability of phosphonic acid
monolayers on a Ti6Al4V surfacewas investigated. Following the stabil-
ity of the monolayers, a novel approach was used to bind Paracetamol
covalently to monolayers adsorbed on the SLM fabricated Ti6Al4V
surface.
2. Materials and methods
2.1. Materials
Gas atomised grade 5 titanium alloy, Ti6Al4V powder, with an aver-
age particle size distribution (volume weighted) of 33.35 μmwas pur-
chased from LPW Technology Ltd., UK. Silicon carbide grits, polishing
cloth, diamond paste and extender solutions were supplied by Buehler
(Buehler-met® II). 16-Phosphanohexadecanoic acid (16-PhDA) (97%)
and Paracetamol (analytical grade) used for the surface modiﬁcation
were purchased from Sigma-Aldrich, UK. Thionyl chloride (97%), tetra-
hydrofuran (THF), hydrogen peroxide (30%) and sulphuric acid (98%)
used for the cleaning and surface modiﬁcation steps were also pur-
chased from Sigma-Aldrich, UK. THF used for binding Paracetamol to
monolayers was dried using benzophenone/sodium under argon atmo-
sphere. This is referred in this study as “dry THF”.
2.2. Methods
2.2.1. Design and fabrication
Cuboidal Ti6Al4V parts with dimensions 10 × 10 × 3 mmwere fab-
ricated in a SLM250 lasermeltingmachine (Renishaw, UK) using a laser
power of 200W, hatch spacing of 100 μm, exposure time of 200 μs and a
layer thickness of 50 μm. AMeander scan strategy was used to build the
part. The theory behind the SLM process and its working principles can
be found in literature [25]. After fabrication, the parts were removed
from the build plate and sonicated in deionised water.2.2.2. Sample preparation
The SLM-built samples were mechanically polished using a series of
silicon carbide grits including 220 μm, 400 μm, 600 μm, 800 μm and
1200 μm diameter, for 5–7 min. These surfaces were then polished for
3 min with a polishing cloth using 6 μm and 1 μm diamond pastes.
The mechanically polished surfaces were rinsed with deionised water
and then immersed in a mixture of sulphuric acid, hydrogen peroxide
andwater in the ratio of 1:1:5 respectively for 15min to remove surface
contaminants. Finally the surfaceswere sonicated in deionisedwater for
30 min (twice) to remove any traces of residual acids.
2.2.3. Self-assembly of monolayers
A solution immersion deposition method was used to coat 16-PhDA
phosphonic acid SAMs on the mechanically polished Ti6Al4V plates.
SAMs were deposited on the sample surfaces using a procedure previ-
ously reported in the literature [17]. Brieﬂy, 1 mM solution of 16-
PhDA in 150 ml THF was prepared. After 24 h, the samples were
removed from the THF and any residual solution was allowed to evapo-
rate in air. Without rinsing, the samples were immediately transferred
to an ovenmaintained at 120 °C. After 24 h, the SAM-coated specimens
were removed from the oven and allowed to cool to room temperature
before ultrasonicating in THF and deionised water for 1 min each.
2.2.4. Stability studies
The stability of the phosphonic acid monolayers assembled on the
SLM fabricated Ti6Al4V surfaces was studied by immersing the SAM-
coated samples in 20 ml of 10 mM Tris–HCl buffer solution (TBS) with
a pH of 7.4. The samples were incubated at 36.5 °C for 6 weeks. The
samples were removed from the TBS solution at 1, 2, 4 and 6 week
time intervals and ultra-sonicated with deionised water for 1 min and
dried with compressed air before characterisation.
2.2.5. Drug attachment
The SAM coated sampleswere transferred to a round bottomed ﬂask
(RBF) with the SAM coated surface facing upwards. The apparatus
consisted of a RBF ﬁtted to a reﬂux condenser. The entire reaction was
carried out in a nitrogen atmosphere. The apparatus was dried using a
ﬂame/heat gun (an apparatus that produces ﬂame) before use to re-
move anymoisture. 20ml of anhydrous THF was added to the RBF con-
taining the samples through a side tube followed by the addition of
1 mM of thionyl chloride (SOCl2). Care was taken to ensure that the
mixture of THF and SOCl2 added to the RBF covered the sample surface.
The RBF together with the samples and SOCl2 mixture were sonicated
for an hour before syringing out the mixture from the RBF. Now the
SOCl2 reacted surfaces were sonicated thrice (for 2 min each time)
using excess anhydrous THFwithout exposing the surfaces to the atmo-
sphere. If exposed to the atmosphere, the chlorinated SAMswould have
reactedwith atmospheric airmoisture and the acid chloridewould have
hydrolysed back to the carboxylic acid. After rinsing the samples, 5 mM
of Paracetamol in 20 ml of anhydrous THF was added to the RBF and
sonicated for an hour. Finally, the surfaces in the RBF were sonicated
with an excess of anhydrous THF and deionised water thrice (each for
2 min) and characterised using XPS. Fig. 1 shows a schematic of the
chemical reaction that took place at each step to bind the drug to the
monolayers.
2.2.6. Surface characterisation
2.2.6.1. Surfacemorphology. The surfacemorphology of the SLM fabricat-
ed samples was imaged using a LEO 440 scanning electron microscope
(SEM). SEM was operated at an extra-high tension (EHT) power of
10 kV and micrographs of the surfaces were obtained at magniﬁcations
including 50× and 500×.
2.2.6.2. Surface roughness. Surface roughness (Ra) measurements
of the SLM as-fabricated samples and the mechanically polished
Fig. 1. General reaction scheme to functionalise 16-PhDA SAMs with Paracetamol. Label description: 1. Hydroxylated titanium surface; 2. 16-Phosphanohexadecanoic acid; 3. SAMs
adsorbed on a Ti6Al4V surface; 4. Chlorinated surface; 5. Ti6Al4V surface functionalised with Paracetamol.
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measurement device. Surface roughness patterns were obtained
from a 175 μm × 175 μm square area of the sample. Surface roughnessFig. 2. SEMmicrographs showing the surfacemorphology of a typical SLM as-fabricated (a and bwas measured for ﬁve samples and averaged. The data acquired
was processed using the in-built software within the Alicona
InﬁniteFocus®.) Ti6Al4V surface (Magniﬁcations 50× and 500×) and amechanically polished surface (c).
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Fig. 3. Survey spectra showing the change in surface chemistry of a Ti6Al4V surface after
SAM attachment. (a) Control surface without SAM coating and (b) after 16-PhDA SAM
coating.
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Fig. 4.High resolution spectra of phosphorous 2p region conﬁrming the attachment of 16-
PhDA monolayers to the Ti6Al4V surface.
55J. Vaithilingam et al. / Materials Science and Engineering C 46 (2015) 52–612.2.6.3. Surface wettability. Surface wettability of the samples before and
after surface modiﬁcation (SAM attachment and drug attachment) was
determined by static water contact angle measurement using a contact
angle goniometer (OCA-20). A drop volume of 2 μl was placed on the
surface and allowed to settle for approximately 5 s. The contact angle
formed by the water drop on the sample surface was measured using
the inbuilt software SCA 20. Contact angles were measured in ﬁve dis-
tinct spots within the sample surface and averaged.
2.2.6.4. Surface chemistry. X-ray photoelectron spectroscopy (XPS) mea-
surements were performed using a Thermo Scientiﬁc K-Alpha ESCA
with a probing spot size of 400 μm. Using aluminium (Al) Kα
monochromated radiation at 1486.6 eV, photoelectrons were collected
using a take-off angle of 90°. In a constant analyser energymode, survey
spectra were collected at a pass energy of 100 eV and high resolution
spectra were obtained at a pass energy of 20 eV. Peak deconvolution
was performed using Gaussian–Lorentzian curves to investigate the dif-
ferent chemical states of the detected elements. A built-in Thermo Sci-
entiﬁc Avantage data system was used for data acquisition and
processing. Previously reported works and the National Institute of
Standards and Technology (NIST) database were used to identify the
spectral lines.
3. Results and discussion
3.1. Surface morphology
The surface morphology of a typical SLM-fabricated Ti6Al4V sample
is shown in Fig. 2. Partially sintered particles observed in the micro-
graph show that the SLM fabricated samplewas rough. The average sur-
face roughness (Ra) obtained using a surface proﬁlometer was 17.6 ±
3.7 μm. The reason for such sintering of particles to the surface could
bedue tomultiple factors including as a natural consequence of building
parts from a powder bed, equipment based process parameters such as
laser power, and laser beam spot size [28–30].
Some biomedical applications require a smooth surface (such as
stents) to avoid cellular damage and some require a rougher, porous
surface to promote cell adhesion and tissue integration and regenera-
tion [13]. Although the SLMas-fabricated parts cannot be used for appli-
cations that require a smooth surface ﬁnish, they could be used where aTable 1
Relative atomic percentage of the elements detected in XPS.
Sample Relative atomic percentage
C O N Ti
Control 21.8 ± 1.7 54.5 ± 2.1 0.2 ± 0.8 18.2 ±
16-PhDA SAM 51.1 ± 2.3 32.9 ± 1.4 2.0 ± 0.5 8.7 ±porous surface is required. However, the SLM-produced surfaces are po-
rous due to partially and loosely sintered particles. These particles could
detach from the surface and can cause acute and chronic effects.
In addition, if particles detach after monolayer assembly, areas will
be left without drug attachment since there will be no underlying
monolayer to functionalise. XPS and contact angle measurements are
sensitive to rough surface and hence, the use of SLM as-fabricated sur-
face will affect the surface characterisation results. Hence in this study,
the SLM fabricated surfaces were mechanically polished to remove the
partially-sintered particles and to attain a smooth surface before surface
modiﬁcation and functionalisation with a drug. The average surface
roughness (Ra) of the mechanically polished surfaces obtained using a
surface proﬁlometer was 0.437 ± 0.045 μm.3.2. Monolayer attachment
Fig. 3 shows the survey spectra obtained from the mechanically
polished Ti6Al4V surface before and after surface modiﬁcation using
16-PhDA SAMs. The spectra clearly indicate the introduction of a
metal phosphonate peak at 133.3 eV showing that the surface has
been modiﬁed with 16-PhDA monolayers. This metal phosphonate
peak is due to the formation of Ti\O\P bonds after SAM attachment
[31,32]. This has further been justiﬁed by an increase in the intensity
of carbon and a reduction in the intensity of oxygen, titanium and alu-
minium after surface modiﬁcation (due to the limited penetration
depth of XPS measurements, less of the underlying metal and oxide is
detected).
Table 1 shows the relative atomic composition obtained for the
Ti6Al4V surface before and after surface modiﬁcation. For a surface
modiﬁed using 16-PhDA, the expected ratio of C:P is 16:1 and in the cur-
rent study, it is observed to be nearly the same (i.e. 15.6:1). The small
variation is likely due to errors in the integration of the small phospho-
rous peak. High resolution spectra obtained for the phosphorous 2p re-
gion showed the formation of metal–phosphonate bond at 133.6 eV
(Fig. 4) conﬁrming the modiﬁcation of the surface with monolayers
[31].Al V P Cl S
0.9 4.7 ± 0.7 0.6 ± 0.2 0 0 0
1.1 1.8 ± 0.7 0.3 ± 0.1 3.3 ± 0.5 0 0
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Fig. 5. XPS spectra for the phosphorous 2p region showing the stability of monolayers on
the SLM fabricated Ti6Al4V surface at various time intervals.
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56 J. Vaithilingam et al. / Materials Science and Engineering C 46 (2015) 52–61The average static contact angles obtained from the surface before
and after surface modiﬁcation with SAMs were 23.7° ± 3.4° and
35.1°±7.1° respectively. The contact angles can be observed to increase
after SAM attachment showing a change in the surface wettability.
However, since 16-PhDA SAMs are hydrophilic, displaying a carboxylic
acid (COOH) terminal group, the surface remained highly wettable
even after surface modiﬁcation.0 200 400 600
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Fig. 7. Survey spectra obtained using XPS for the SAM coated and Paracetamol coated surfaces.
change in the surface chemistry.3.3. Stability studies
Stability of the 16-PhDA monolayers on the SLM fabricated Ti6Al4V
surface was studied by immersing the SAM coated samples into Tris–
HCl buffer solution. Fig. 5 shows the high resolution XPS spectra for
the phosphorous 2p region of the samples soaked in the buffer solution
for different time intervals. It can bewitnessed from the spectra that the
metal phosphonate peak at 133.3 ± 0.6 eV retained its position at the
same binding energy for the whole duration of immersion in the buffer
solution. However, its intensity and relative atomic composition de-
creased over the course of the experiment showingdesorption ofmono-
layers from the Ti6Al4V surface. Although the desorption of monolayers
was noted to occur after four weeks, a small amount of monolayers was
observed at the end of six weeks. The phosphorous 2p peak showed a
small peak shift upon immersing the substrate in Tris–HCl buffer solu-
tion. This may be due to the charging effect of the substrate during
XPS characterisation [33].
A gradual increase in the contact angle was noted after immersing
the samples in Tris–HCl buffer solution (although this change has low
signiﬁcance compared to the standard deviations of individual mea-
surements). This may be attributed to a small amount of desorption
(Fig. 6) leading to the change in the assembly pattern of themonolayers.
Thus, both the XPS characterisation and static water contact angle mea-
surements conﬁrm that 16-PhDA monolayers are relatively stable on
the Ti6Al4V surface for more than the 28 day time period when soaked
in Tris–HCl buffer solution. A previous study showed that 16-PhDA
SAMs are stable on both SLM as-fabricated (SLM-AF) surface and a me-
chanically polished SLM surface (SLM-MP) for over 28 days [34]. This
study also revealed that the surface roughness did not signiﬁcantly af-
fect the stability of the 16-PhDA monolayers formed on these rough
(SLM-AF) and smooth (SLM-MP) surfaces.
3.4. Functionalisation of 16-PhDA monolayers with Paracetamol
After studying the stability of monolayers on the Ti6Al4V surface, a
sample drug (Paracetamol)was used to functionalise the SAMs. The reac-
tive carboxylic acid group at the tail end of 16-PhDA SAMs was reacted
with thionyl chloride (SOCl2) to form an intermediate acid chloride com-
poundwith\COCl as the terminal group. This groupwas then allowed to
reactwith the hydroxyl (\OH)group of Paracetamol to bind the drug co-
valently to themonolayers. Thewhole reaction stepwas performed in an
inert atmosphere. Anhydrous THFwas used to prevent the SOCl2 reacting
with moisture in the atmosphere to form HCl that could corrode the
metal surface and also hydrolyse the\COCl to inactive\COOH.
Fig. 7 shows the survey spectra for the Ti6Al4V sample before and
after drug attachment. The corresponding atomic percentages are800 1000 1200
rgy (eV)
O (A)
16-PhDA SAMs only
16-PhDA SAMs+Paracetamol
Changes in the intensity of the detected elements before and after drug coating indicate a
Table 2
Relative atomic percentage of elements detected by the XPS on SAM coated and Paracetamol coated Ti6Al4V surface.
Sample Relative atomic percentage
C O N Ti Al V P Cl S
16-PhDA SAM 51.1 ± 2.3 32.9 ± 1.4 2.0 ± 0.5 8.7 ± 1.1 1.8 ± 0.7 0.3 ± 0.1 3.3 ± 0.5 0 0
SAM + Paracetamol 48 ± 1.8 35.8 ± 1.6 4.5 ± 0.7 7.8 ± 1.3 1.1 ± 0.5 0 1.2 ± 0.4 0.8 ± 0.2 0.9 ± 0.1
57J. Vaithilingam et al. / Materials Science and Engineering C 46 (2015) 52–61given in Table 2. It can be clearly noted that there is a signiﬁcant change
in the surface chemistry of the SAM-coated Ti6Al4V surface after the at-
tachment of Paracetamol. The ratio of C:P was 15.6 for SAM coated sur-
face and after the attachment of Paracetamol the ratio of C:N was 10.7.
These ratios show the reduction in the atomic percentage of carbon
after drug attachment since less carbon-rich Paracetamol contains 8 car-
bon atomswith 3 heteroatoms compared to 16-PhDA (which presents a
carbon-rich surface due to a long alkyl group and buried phosphonate).
However, there are possibilities for small errors since nitrogen is present
in the atmosphere as a contaminant [35].
Due to the presence of nitrogen in Paracetamol, its concentration
was noted to increase; however, this is not a large increase since the
drug molecule contains only one nitrogen atom. The concentration of
phosphorous (from 16-PhDA) and the underlying metals (titanium, al-
uminium and vanadium) were observed to decrease and this further
conﬁrms the functionalisation of SAMs with Paracetamol.
A very small contribution from chlorine and sulphur was observed
after the attachment of Paracetamol and this is likely to be added from
the SOCl2 used in the intermediate step. Since the 16-PhDA SAMs
have 2 hydroxyl groups (\OH) in each head group, there may be the
possibility for the addition of chlorine or the sulphur to those hydroxyl
ends to form Ti\O\P\OCl-alkyl chain and/or Ti\O\P\S-alkyl chain.
Although the abovementioned reaction is possible, it depends only on
the availability of a hydroxyl group for the reaction as both hydroxyl
groups can bond to the Ti6Al4V surface initially before reaction of the
SAMs.
Carbon contamination is unavoidable as it is present as a contami-
nant in the atmosphere. However, a small amount of nitrogen was
also observed on the Ti6Al4V sample as a contaminant in both the con-
trol and SAM coated surfaces. The presence of these elements on the
metal oxide surface as contaminants was reported in literature [23,
31]. Hence the ratio of carbon to the underlying metal composition of
the surface has been used to determine the adsorption of SAMs and
Paracetamol to the metal surface.
Fig. 8 shows the ratio of carbon and oxygen to the underlyingmetals
(titanium+ aluminium and vanadium) and the ratio of carbon to oxy-
gen for all three samples (control, SAM attached and Paracetamol coat-
ed). It can be observed that the carbon and oxygen concentration
increased after SAM attachment and functionalisation conﬁrming the
attachment of the Paracetamol to the tail group of 16-PhDAmonolayers.
A comparison of the C 1s spectra obtained for the control, 16-PhDA
SAM coated and SAMs functionalised with Paracetamol is shown inXP
S
Ra
o
s
0
1
2
3
4
5
6
C/Metals (Ti+Al+V) O/Metals (Ti+Al+V)
Co
SA
SA
ntr
M o
M+
ol
nly
Pa
C/O
racetamol
Fig. 8. Ratio of carbon and oxygen to its underlying metals and C/O ratio for control, SAM
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286.2 eVwere assigned to C\C and C\O of hydrocarbon contaminants.
Adsorption of hydrocarbon as contaminants to metal oxide surfaces has
been discussed in literature and the major source for these contami-
nants is adventitious carbon in air, solvents (used for cleaning)
and from hydrocarbons (containing proteins and oils) due to manual
handling [35–38].
The C 1s spectrum for the SAM coated Ti6Al4V surface was
deconvoluted into three components. The peaks observed at 284.9 eV,
286.5 eV and 289.3 eVwere assigned to C\C, C\O and C_O [23]. A sig-
niﬁcant increase in the relative C\C peak intensity compared to the
control surface was due to the 16 membered carbon chain [HOOC
(CH2)15PO(OH)2] in the 16-PhDA molecule. The C\O and C_O are
also from the 16-PhDA molecule, present in the head and tail group of
the chain. The signiﬁcant change in the intensity of C\C, and C\O
and the introduction of C_O peak conﬁrms the modiﬁcation of SLM
fabricated Ti6Al4V surface with 16-PhDA monolayers.
On characterising the Ti6Al4V surface functionalised with Paraceta-
mol, the deconvoluted C 1s spectrum rendered four components at
284.7 eV, 285.8 eV, 286.9 eV and 289.1 eV. These peaks can be assigned
to C\C, C\O, C\N and C_O respectively [17,23]. Comparing this to the
SAM coated surface, the peak intensity of C\C and C_O has changed.
Also the introduction of C\N peak at 286.9 eV was observed. This
C\N peak is from the amide group in Paracetamol.
Paracetamol powder in its pure form (as purchased) was char-
acterised using XPS to obtain the spectrum for C 1s region (Fig. 9d).
The deconvoluted spectrum showed the existence of four components
C\C (284.7 eV), C\O (286 eV), C\N (288.2 eV) and C_O (291.2 eV)
[23,39]. These peaks can be assigned to carbon atoms in hydrocarbon,
hydroxyl, amide and ester groups of Paracetamol. The XPS results ob-
tained for Paracetamol coated Ti6Al4V surface was in good agreement
with the results obtained for the C 1s region of Paracetamol powder.
However, a small change in the peak binding energies was noted and
this could be due to errors in peak integration during deconvolution
and might also be due to minor calibrating errors due to sample
charging.
The O 1s region spectrum obtained using XPS for the control sample
(Fig. 10a) was deconvoluted into two components, metal oxide at
530.5 eV and oxygen atoms in O\C at 532.1 eV [40–42]. The metal
oxide peak observed at 530.5 eV is likely to be mostly due to titanium
oxide; however, a small proportion of aluminium and vanadium oxides
is also possible due to the presence of these elements in Ti6Al4V alloy. In
agreement with the C 1s spectrum, the O 1s spectrum also showed the
existence of O\C species on the control sample as contaminants.
On deconvoluting the O 1s spectrum for the 16PhDA SAM coated
Ti6Al4V surface, three components were obtained (Fig. 10b). The
peaks formed at 530.4 eV, 531.9 eV and 533.2 eV were assigned to
metal oxides, O\C and O_C respectively [41–43]; however, there is
also the possibility for a small contribution from aluminium oxide for
the peak observed at 531 eV. The relative intensity of metal oxide
peak at 530.4 eV for the SAMcoated sample can be observed to decrease
and theO_C peak at 533.2 eV to increasewhen compared to the control
sample. The introduction of O_C at 533.2 eV shouldmostly derive from
the carboxylic group at the terminal end of the 16-PhDA molecule.
These observed changes compared with the control sample can be at-
tributed to the adsorption of 16-PhDA monolayers on to the SLM fabri-
cated Ti6Al4V surfaces.
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Fig. 9. High resolution spectra of carbon 1s region obtained for (a) control, (b) SAM attached, (c) Paracetamol coated samples, (d) shows the C 1s region for Paracetamol powder
characterised using XPS.
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Fig. 12. Contact angles obtained for SLM fabricated Ti6Al4V surfaces after a) cleaning b) 16-PhDA SAM attachment, c) Paracetamol attachment.
59J. Vaithilingam et al. / Materials Science and Engineering C 46 (2015) 52–61After functionalising SAMswith Paracetamol, the deconvoluted O 1s
XPS spectrum rendered three componentsmetal oxide (530.8 eV), O\C
(532.1 eV) and O_C (533.4 eV) and are shown in Fig. 10a. Although the
O\C and O_C are expected only from Paracetamol, a small contribu-
tion from the underlying monolayers is possible. The XPS characterisa-
tion of Paracetamol powder for the O 1s region rendered two
components including O\C (531.7 eV) and O_C (533.1 eV) on
deconvolution [41] as shown in Fig. 10d. On comparing the
deconvoluted O 1s peaks obtained for the Paracetamol coated surface
with the O 1s peaks obtained for the Paracetamol powder, both the
peaks were in good agreement. However, there was a slight variation
in the binding energies. This further conﬁrms the attachment of Paracet-
amol to the 16-PhDA adsorbed Ti6Al4V surface.
DeconvolutedN 1s spectrum showed the presence of N\C andN\O
at 400.3 eV and 402.6 eV respectively on the control surface (Fig. 11a).
Although nitrogen is not expected on the Ti6Al4V surface (as it is not
in the composition), a small amount of nitrogen was observed. Similar
to carbon, nitrogen also has strong afﬁnity towards metal oxides and
their presence on metal oxide surfaces could be from nitrogen contain-
ing carbon contaminants [23]. Similar to the control sample, the SAM
coated surface also showed the existence of nitrogen at 400.1 eV
(N\C) and 402.3 eV (N\O) after deconvolution (Fig. 11b) [37]. This
could also be from contamination of the surface as the peaks were ob-
served similar to the control samples. Furthermore, the 16-PhDA
SAMs do not have nitrogen in their structure.
The deconvolutedN 1s spectrum for the Paracetamol coated Ti6Al4V
surface also showed two components, N\C at 400.1 eV and N\O at
401.9 eV (Fig. 11c). Although a small contribution to these peak from
contaminants is possible since the other samples (control and SAM
coated) were shown to have contaminants, the N\C peak is distinct
and increased in relative intensity. XPS characterisation of Paracetamol
powder for the N 1s region showed a single N\C peak at 400.3 eV
(Fig. 11d).
Wettability of a surface is inﬂuenced by its surface roughness, ﬁlm
thickness and its chemical composition/functional group [44]. The as-C
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Fig. 13. Static water contact angle obtained for control, SAM coated and Paracetamol coat-
ed Ti6Al4V samples.fabricated SLM surfacewas rough and this may have affected thewetta-
bility. Hence a mechanically polished surface was used. Static contact
angles obtained for the control, 16-PhDA SAM attached and Paraceta-
mol coated surfaces are shown in Fig. 12. Fig. 13 shows the contact
angle values obtained graphically. It can be observed that the control
and 16-PhDA SAM deposited surfaces were highly wettable whereas
the Paracetamol coated surface was more hydrophobic. The wettability
of the surface cleaned control surface was due to the presence of metal
oxides which impart a high surface energy. Wettability of the 16-PhDA
SAM coated surfaces was due to the presence of carboxylic acid in their
terminal group. Since the SAM coated surface was functionalised with
Paracetamol, it would be expected that a methyl group (\CH3) is ex-
posed as the terminal group leading to a lower energy surface. In agree-
ment with this, the measured contact angles showed the Paracetamol
coated surface to be more hydrophobic with a contact angle higher
than 90°. Thus, both the XPS characterisation and surface wettability
measurements are consistent with the attachment of Paracetamol to
the 16-PhDA SAMs and functionalisation of SLM fabricated Ti6Al4V sur-
face with Paracetamol.
4. Conclusion
16-PhDA phosphonic acid SAMswere successfully attached to a SLM
fabricated Ti6Al4V surface. The 16-PhDA SAMs were stable on the sur-
face for more than 28 days when immersed in Tris-buffer solution be-
fore signiﬁcant desorption from the surface was observed. Changes
observed in the surface chemistry of the Ti6Al4V surface at each stage
through XPS characterisation and surface wettability measurements
are consistent with the functionalisation of monolayers with Paraceta-
mol. This study showed the attachment and stability of 16-PhDA
SAMs on SLM fabricated Ti6Al4V surface and the successful immobilisa-
tion of Paracetamol to 16-PhDA SAMs. However, nitrogen and carbon
alone cannot be used as a key element to conﬁrm the Paracetamol at-
tachment, since they are present on the surfaces as a contaminant and
may affect the result. Hence, Paracetamol may not be the ideal drug of
choice to prove the immobilisation of the drug to SAMs. The use of
drugs with other elements that are unlikely to be present in the atmo-
sphere as contaminants could be used to prevent contamination affect-
ing the results in future studies.
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